Locations
Draft Order including new substances in Annex 1 to Royal Decree 2829/1977 of 6 October 1977 regulating psychotropic medicinal substances and preparations, as well as the control and inspection of their manufacture, distribution, prescription and dispensation.
The public hearing is opened for the draft Order including new substances in Annex 1 to Royal Decree/1977 of 6 October 1977 regulating psychotropic medicinal substances and preparations, as well as the control and inspection of their manufacture, distribution, prescription and dispensation.
The aim of the proposal is to incorporate new psychoactive substances that have been placed under international control measures by decisions of the United Nations Commission on Narcotic Drugs.
The deadline for contributions expires on 13 February 2025.
Royal Decree implementing Law 3/2024, of 30 October, to improve the quality of life of people with Amyotrophic Lateral Sclerosis and other highly complex and irreversible diseases or processes, with regard to the list of diseases and processes to which it will be applicable.
The Draft Royal Decree implementing Law 3/2024, of 30 October, to improve the quality of life of people with Amyotrophic Lateral Sclerosis and other highly complex and irreversible diseases or processes is out for public consultation.
In particular, contributions can be made on the criteria for the definition of the diseases and processes to which the law will be applicable, and the list of diseases and processes to be included in the annex to the Royal Decree.
The deadline for contributions is 9 February 2025.
Incentives in Royal Decree 1416/1994 of 25 June 1994 regulating the advertising of medicinal products for human use.
The Generalitat de Catalunya published an informative note on the regulation of the incentives provided for in article 3.g) of Royal Decree 1416/1994 of 25 June 1994, which regulates the advertising of medicinal products for human use.
In particular, the informative note focuses on particularly practical aspects of incentive regulation in order to promote the ethical promotion of medicines.
This informative note is available on the website of the Generalitat de Catalunya.